(Q37742790)

22 August 2017

0 references

1 reference

title

Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis (English)

1 reference

major depressive disorder

22 August 2017

0 references

0 references

1 reference

J Guidi

1

1 reference

22 August 2017

G A Fava

series ordinal

2

1 reference

22 August 2017

M Fava

series ordinal

3

1 reference

22 August 2017

G I Papakostas

series ordinal

4

1 reference

22 August 2017

language of work or name

English

0 references

publication date

6 May 2010

1 reference

22 August 2017

Psychological Medicine

1 reference

22 August 2017

41

1 reference

22 August 2017

321-331

1 reference

22 August 2017

2

1 reference

Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine.

22 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Integrating cognitive therapy and pharmacotherapy in the treatment and prophylaxis of depression: a novel approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Combined pharmacotherapy and psychological treatment for depression: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

The selection and design of control conditions for randomized controlled trials of psychological interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Interpersonal psychotherapy delivered over the telephone to recurrent depressives. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Mental health clinics in the 21st century.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

The aftermath of the concept of 'psychiatric comorbidity'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Mindfulness-based cognitive therapy to prevent relapse in recurrent depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Maintenance treatment in recurrent depression: current and future directions. The first William Sargant Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

An evaluation of the 'Coping with Depression Course' for relapse prevention with unipolar depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Treatment of Depression by Drugs and Psychotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Mindfulness-based cognitive therapy for residual depressive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

The road to recovery from depression--don't drive today with yesterday's map.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Well-being therapy of generalized anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Course of depression in patients with comorbid anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Fifty years with the Hamilton scales for anxiety and depression. A tribute to Max Hamilton.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Challenges in preventing relapse in major depression. Report of a National Institute of Mental Health Workshop on state of the science of relapse prevention in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Effects of meditation on frontal alpha-asymmetry in previously suicidal individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Effects of cognitive therapy on psychological symptoms and social functioning in residual depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Well-being therapy. A novel psychotherapeutic approach for residual symptoms of affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Prodromal symptoms in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Short psychodynamic supportive psychotherapy, antidepressants, and their combination in the treatment of major depression: a mega-analysis based on three randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Mindfulness-based cognitive therapy reduces overgeneral autobiographical memory in formerly depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Mindfulness-based Cognitive Therapy (MBCT) in bipolar disorder: preliminary evaluation of immediate effects on between-episode functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Continuation and maintenance use of antidepressants in recurrent depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Cognitive behavior approach to loss of clinical effect during long-term antidepressant treatment: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

Sequential treatment of mood and anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Long-term outcome of panic disorder with agoraphobia treated by exposure.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Maintenance treatment of major depression in old age

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Prevention of relapse in residual depression by cognitive therapy: a controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Cognitive behavioral treatment of residual symptoms in primary major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Reducing relapse in depressed outpatients with atypical features: a pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Is there a role for continuation phase cognitive therapy for depressed outpatients?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Does a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Three-year outcomes for maintenance therapies in recurrent depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Use of cognitive therapy for relapse prevention in chronic depression. Cost-effectiveness study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Prediction of Recurrence in Recurrent Depression and the Influence of Consecutive Episodes on Vulnerability for Depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Family intervention approach to loss of clinical effect during long-term antidepressant treatment: a pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Long-term outcome of social phobia treated by exposure

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Controlled acute and follow-up trial of cognitive therapy and pharmacotherapy in out-patients with recurrent depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

The Combination of Estimates from Different Experiments

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Preventing Relapse/Recurrence in Recurrent Depression With Cognitive Therapy: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Prevention of recurrent depression with cognitive behavioral therapy: preliminary findings

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Residual symptoms after partial remission: an important outcome in depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Addressing ethical issues in the psychiatric research literature.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Six-year outcome of cognitive behavior therapy for prevention of recurrent depression.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

Metacognitive awareness and prevention of relapse in depression: empirical evidence.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291710000826

7 January 2021

10.1017/S0033291710000826

Identifiers

DOI

1 reference

22 August 2017

1 reference